However, this approach may not fully overcome tumor-driven immune evasion mechanisms, such as the production of prostaglandin E2 or transforming growth factor-β, recruitment of MDSCs, secretion of interleukin-10, and the increase of regulatory T cells and tumor-associated macrophages, all of which warrant further investigation. The gene discussed is IL10; the disease is neoplasm.